'This Isn't Jurassic Park' New Doc Explores the Science Behind the 'De-Extinction' of Dire Wolves and Other Animals
A new documentary plans to reveal the scientific breakthroughs that made this "de-extinction" possible. De-Extinction premieres July 17 on Curiosity Stream, and PEOPLE has a first look at the trailer for the upcoming project.
The trailer for the documentary opens with a discussion of the "biodiversity problem" facing the Earth — the threat of half the world's species going extinct by 2050.
Some experts who spoke with De-Extinction believe the way to combat this potential crisis is to "dig into the past and bring some of these really important species back."
Colossal Biosciences is pursuing this plan, having already revived the dire wolf using grey wolf DNA, and is working on projects to bring back the giant moa bird and other extinct animals. In the trailer, the woolly mammoth and Tasmanian tiger are also mentioned as candidates for "de-extinction."
The documentary promises to do more than talk about animals from the past. According to De-Extinction, the film aims to show how scientists are bringing back bygone species, and discuss the ethical dilemmas emerging from the advancement of this new field.
"This isn't Jurassic Park. It's real science and real stakes, which can be much messier than people think." John Cavanagh, the doc's executive producer, teased in a statement with PEOPLE.
"This is an incredible breakthrough. Genetic research has let us understand evolution like never before. De-extinction captures the potential of this moment, showing how radical science could shape the future of life on Earth. But it's also a sobering look at what's at stake," he added.
Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.
De-Extinction will take viewers to labs around the world, where researchers are working on a variety of groundbreaking projects that they consider key to protecting the planet's biodiversity.
To learn more about the science that seems straight out of science fiction, tune into De-Extinction available on Curiosity Stream starting July 17.
Read the original article on People
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Geek Girl Authority
an hour ago
- Geek Girl Authority
Untamed Archives
Categories Select Category Games GGA Columns Movies Stuff We Like The Daily Bugle TV & Streaming
Health Line
an hour ago
- Health Line
Understanding the Stages of Multiple Myeloma
Key takeaways Multiple myeloma is a cancer of the blood that affects plasma cells, and its progression is determined using the Durie-Salmon Staging System or the Revised International Staging System (RISS). The stages of multiple myeloma range from 0 to 3, with higher stages indicating that the cancer has spread and will likely require more intensive treatment. Treatments for multiple myeloma include drug therapies, radiation, and stem cell transplants. Multiple myeloma is a blood cancer that forms in the white blood cells produced by bone marrow. Doctors stage multiple myeloma based on the levels of proteins produced by cancerous cells found throughout the body and other clinical factors affected by cancer. A higher stage means that the cancer has progressed and spread (metastasized). Typically, a higher stage, like stage 3, also causes more symptoms and requires more aggressive treatment. What is multiple myeloma? Multiple myeloma is a type of blood cancer that forms in plasma cells. Plasma cells are a type of white blood cell. Healthy plasma cells are an important part of the immune system and help the body fight infections. When multiple myeloma develops, cancerous plasma cells form. These plasma cells don't help your body fight infection. Over time, these cells multiply and overwhelm your healthy plasma cells. How is multiple myeloma diagnosed and staged? Tests such as bloodwork can help detect multiple myeloma. Blood tests can show the presence of proteins made by cancerous plasma cells. If your doctor suspects multiple myeloma, you might also be asked to do a bone marrow biopsy since plasma cells are produced in your bone marrow. Sometimes, imaging tests such as X-rays or MRIs are done to look for bone damage and other signs of multiple myeloma. Multiple myeloma is staged using the Durie-Salmon Staging System or the Revised International Staging System (RISS). Durie-Salmon Stage System stages of multiple myeloma The Durie-Salmon Stage System assigns stages by looking at: level of kidney function level of blood calcium hemoglobin concentration amount of M protein in blood and urine presence of bone lesions in imaging studies Stage Criteria I • hemoglobin level > 10 g/dL • serum calcium level < 10.5 mg/dL • a normal bone structure or solitary bone plasmacytoma assessed with conventional radiography • low rate of M-component production (IgG level < 5 g/dL; IgA level < 3 g/dL • Bence Jones protein level < 4 g/24 h II Neither stage I nor stage III III One or more of the following: • hemoglobin value < 8.5 mg/dL • serum calcium level > 12.5 mg/dL • advanced lytic bone lesions assessed with conventional radiography • high M-component production rate (IgG value > 7g/dL; IgA value > 5 g/dL; Bence Jones protein > 12 g/24 h) RISS stages of multiple myeloma The RISS assigns stages by looking at: amount of albumin in blood amount of LDH in blood amount of beta-2 microglobulin in blood gene abnormalities of multiple myeloma Below we break down the RISS stages for multiple myeloma and their treatments: Stage 0 multiple myeloma Stage 0 is sometimes called smoldering multiple myeloma or asymptomatic multiple myeloma. At this stage, there are often no symptoms. Clinical criteria for Stage 0 include: blood counts, calcium levels, and kidney function are all normal no bone or organ damage no evidence of amyloid protein buildup serum monoclonal protein greater than or equal to 30 g/L, urinary monoclonal protein greater than or equal to 500 mg per 24 hours, or clonal bone marrow plasma cells 10–60% Stage 0 multiple myeloma treatment Treatment isn't typically needed at this stage. Instead, careful monitoring and regular testing are used to watch for progression. Stage 1 multiple myeloma Multiple myeloma needs to meet certain criteria. This includes: albumin levels greater or equal to 3.5 g/dL serum beta-2 microglobulin less than 3.5 mg/L cytogenetics that are not classed 'high risk' normal LDH levels You might notice symptoms such as bone pain and weakness in your arms and legs at this stage. Stage 1 multiple myeloma treatment Drug therapies are the primary treatment for multiple myeloma. These therapies aim at destroying multiple myeloma cells and include options such as: proteasome inhibitors chemotherapy steroids antibodies immunomodulatory drugs (IMiDs) b-cell maturation antigen (BCMA)-targeted therapies A treatment plan for stage 1 multiple myeloma might include one or a combination of these drug therapies. You might also have treatments such as radiation therapy or a stem cell transplant, depending on your individual treatment plan. Stage 2 multiple myeloma Stage 2 multiple myeloma needs to meet certain criteria. This includes: beta-2 microglobulin between 3.5 mg/L and 5.5 mg/L cytogenetics are either not high risk or have a risk level that is undefined it's not stage 1 or stage 3 By stage 2, symptoms might be more advanced, including loss of appetite or stomach pain. Stage 2 multiple myeloma treatment Treatment options in stage 2 are the same as the treatment options in stage 1. Drug therapies can be used alone or in combination with options such as radiation therapy or a stem cell transplant. In stage 2, higher doses or more potent drugs might be used. Stage 3 multiple myeloma Stage 3 is the most advanced stage of multiple myeloma. To be classed stage 3, multiple myeloma needs to meet these criteria: cytogenetics are considered high risk serum beta-2 microglobulin equal or greater to 5.5 mg/L high levels of LDH Stage 3 multiple myeloma treatment Treatment by stage 3 is more aggressive to slow and stop the cancer from spreading further. Additional treatments with drug therapies are typically still part of treatment plans. A stem cell transplant might also be an option. You and your team can discuss if this is an option for you. RISS stages for multiple myeloma Bottom line Multiple myeloma is a blood cancer that affects plasma cells. Doctors use certain staging systems to discuss how far multiple myeloma has spread. As multiple myeloma advances, stages increase from 1 to 3. Often, later stages require more aggressive treatment.
Geek Tyrant
2 hours ago
- Geek Tyrant
ALIEN: EARTH Isn't Just Another Creature Feature - Creator Noah Hawley Is Asking Bigger, Scarier Questions — GeekTyrant
Noah Hawley wants you to know Alien: Earth isn't just another run-and-scream from the Xenomorph series. Sure, something terrifying is hiding in the shadows, but Hawley's new FX series digs into something more unsettling than a razor-toothed alien. He's after the horror of us. Hawley tells SFX Magazine in a recent interview: "If you have a story about monsters coming to Earth, the question is, will humanity survive? Then the next question is, does humanity deserve to survive?" That question, about whether we're even worth saving, drives the entire show. Set two years before Alien , the series explores a world on the edge of major corporate domination, staring down both an extraterrestrial threat and its own worst impulses. 'This idea about humanity and the terrible things that we do to each other, it really opened my mind as to the types of horror that would populate the show. Not just body horror or creature horror, but also the moral horror of what people do.' In other words, it's not just facehuggers that should keep you up at night, and I love the concepts that he's looking to explore. Hawley's journey to get Alien: Earth made wasn't smooth. He originally pitched a very different idea: 'I came up with this Lost Boy/Peter Pan transhuman story. But it was pre-Disney [merger] and the film studio 20th [Century Fox] was not, in the end, willing to share the IP. It took a few more years before they were willing.' That long development process gave him time to dig deeper. 'But the good thing about taking all that time is that you stress-test it and you really workshop it and you earn it. It's like that first album, you have your whole life to write those songs and then it's the second album that's the hard one.' Alien: Earth premieres on FX and Hulu in the U.S. on August 12. Get ready for something that goes beyond Xenomorphs, and straight into humanity's rotten core.
